Coulter Pharmaceutical Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$882M
- Investors
-
1
Coulter Pharmaceutical General Information
Description
Operator of a biotechnology company intended to develop therapeutic antibodies and targeted oncologics. The company specializes in developing and discovering antibodies to treat cancer and autoimmune diseases.
Contact Information
Corporate Office
- 600 Gateway Boulevard
- South
- South San Francisco, CA 94080
- United States
Corporate Office
- 600 Gateway Boulevard
- South
- South San Francisco, CA 94080
- United States
Coulter Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 16-Oct-2000 | $882M | Completed | Generating Revenue | ||
| 8. PIPE | 21-Aug-2000 | Completed | Generating Revenue | |||
| 7. 2PO | 01-Jul-1998 | Completed | Generating Revenue | |||
| 6. 2PO | 01-Oct-1997 | Completed | Generating Revenue | |||
| 5. IPO | 01-Jan-1997 | Completed | Startup | |||
| 4. Later Stage VC (Series C) | 16-May-1996 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 28-Aug-1995 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 16-Feb-1995 | $7.5M | $7.5M | Completed | Product Development | |
| 1. University Spin-Out | 01-Jan-1995 | Completed | Startup |
Coulter Pharmaceutical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 7,500,000 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 30.24% |
Coulter Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Coulter Pharmaceutical Patents
Coulter Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2002096910-A1 | Cytotoxins, prodrugs, linkers and stabilizers useful therefor | Inactive | 31-May-2001 | ||
| AU-2001286727-A1 | Prodrugs activated by plasmin and their use in cancer chemotherapy | Inactive | 24-Aug-2000 | ||
| WO-2002015700-A1 | Prodrugs activated by plasmin and their use in cancer chemotherapy | Inactive | 24-Aug-2000 | ||
| WO-2000033888-A2 | Prodrug compounds and process for preparation thereof | Inactive | 11-Dec-1998 | ||
| WO-2000033888-A3 | Prodrug compounds and process for preparation thereof | Inactive | 11-Dec-1998 | A61K47/65 |
Coulter Pharmaceutical Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axiom Venture Partners | Venture Capital | Minority | ||
| Brentwood Venture Capital | Venture Capital | Minority | ||
| Coral Group | Venture Capital | Minority | ||
| Delphi Ventures (California) | Venture Capital | Minority | ||
| InterWest Health Partners | Corporate Venture Capital | Minority |
Coulter Pharmaceutical FAQs
-
When was Coulter Pharmaceutical founded?
Coulter Pharmaceutical was founded in 1995.
-
Where is Coulter Pharmaceutical headquartered?
Coulter Pharmaceutical is headquartered in South San Francisco, CA.
-
What industry is Coulter Pharmaceutical in?
Coulter Pharmaceutical’s primary industry is Biotechnology.
-
Is Coulter Pharmaceutical a private or public company?
Coulter Pharmaceutical is a Private company.
-
What is the current valuation of Coulter Pharmaceutical?
The current valuation of Coulter Pharmaceutical is .
-
What is Coulter Pharmaceutical’s current revenue?
The current revenue for Coulter Pharmaceutical is .
-
How much funding has Coulter Pharmaceutical raised over time?
Coulter Pharmaceutical has raised $210M.
-
Who are Coulter Pharmaceutical’s investors?
Axiom Venture Partners, Brentwood Venture Capital, Coral Group, Delphi Ventures (California), and InterWest Health Partners are 5 of 16 investors who have invested in Coulter Pharmaceutical.
-
When was Coulter Pharmaceutical acquired?
Coulter Pharmaceutical was acquired on 16-Oct-2000.
-
Who acquired Coulter Pharmaceutical?
Coulter Pharmaceutical was acquired by Corixa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
